Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10028


Purpose:

The purpose of this study is to evaluate the clinical efficacy of platelet rich plasma (PRP) injections for non-scaring alopecia in women. A randomized, placebo-controlled clinical trial will be performed where patients with non-scarring alopecia will either receive injections of their own PRP or injections of normal saline (placebo). Patients in the treatment group (Group A) will have a small amount of their own blood drawn and have their PRP injected into their scalp four times. The injections will be given at weeks zero, four, eight, and twenty four. The placebo group (Group B) will be given the same schedule but will receive sham injections only and will not have any blood drawn. Both groups will have clinical data collected at all visits, including a screening visit before enrollment and a final assessment visit at week 40, for a total of 6 study visits per patient. Data collection will include representative photographs of the scalp and measurements of hair thickness. The results from the two groups will then be compared. In summary, all study participants will have a screening visit before enrollment, four study visits for sub-dermal scalp injections, and one final assessment visit at week 40.


Criteria:

Inclusion Criteria: 1. Must understand and voluntarily sign an informed consent form 2. Must be female between the ages of 18 and 65 years at the time of consent 3. Must be able to adhere to the study visit schedule and other protocol requirements 4. Documented platelet count above 150,000 platelets per microliter within 6 months prior to enrollment Exclusion Criteria: 1. Previous or current use in the last 1 year of finasteride, minoxidil topical or oral, or spironolactone 2. A diagnosis of non-androgenic alopecia (i.e: another diagnosis for the alopecia ) 3. No Baseline ferritin, thyroid-stimulating hormone, platelet count, and a negative urine pregnancy test in any pre-menopausal female in past 12 months. 4. Active skin disease (Psoriasis or severe seborrheic dermatitis) of the scalp 5. Scalp infection 6. Severe active blood infection 7. Cuts or abrasions on the scalp 8. History of surgical hair restoration 9. Current or recent malignancy 10. History of systemic chemotherapy or radiation 11. History of thyroid dysfunction 12. History of autoimmune disorder (specifically Graves disease, hashimoto thyroiditis, or systemic lupus erythematosus) 13. Tendency to develop keloids 14. Nonsteroidal anti-inflammatory or Vitamin E discontinued in the last 7-14 days 15. Platelet dysfunction syndrome 16. Thrombocytopenia less than 150,000 17. Diagnosis of hypofibrinogenemia 18. Anticipated pregnancy or trying to become pregnant in the next 2 years


NCT ID:

NCT03689452


Primary Contact:

Principal Investigator
Hooman Khorasani, MD
Icahn School of Medicine at Mount Sinai


Backup Contact:

N/A


Location Contact:

New York, New York 10028
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.